Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.

BACKGROUND--Marked variations in cell size (polymegethism) and shape (pleomorphism) are characteristic of the corneal endothelium in diabetic patients and animals. METHOD--Wide field specular microscopy was used to evaluate the clinical efficacy of treating the diabetic corneal endothelium with topi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ohguro, N, Matsuda, M, Ohashi, Y, Fukuda, M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1995
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC505343/
https://ncbi.nlm.nih.gov/pubmed/8562538
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak